Steven B Miller
CIK 1599611 · EVP, Chief Clinical Officer · last filed 2026-05-07
Steven B Miller is an EVP, Chief Clinical Officer who has filed 38 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for BTSGU, was dated May 7, 2026. Across all open-market trades the lifetime net is −$6.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $14.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.12M
3
38
-$6.43M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BTSGU | Director | 23,106 | $206.38 | $4.77M | $0 | 4 | 2026-05-07 |
| CI | EVP, Chief Clinical Officer | 31,377 | $298.00 | $9.35M | -$3.40M | 11 | 2021-03-02 |
| Express Scripts Holding Co. (ESRX) Delisted | Sr. VP & Chief Med. Officer | 0 | — | — | -$3.03M | 23 | 2018-12-21 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-07 | BTSGU | Grant (A) | +4,983 | $0 | EDGAR |
| 2025-11-06 | BTSGU | Tax (F) | −4,497 | -$147.0K | EDGAR |
| 2025-05-07 | BTSGU | Grant (A) | +11,912 | $0 | EDGAR |
| 2024-11-08 | BTSGU | Grant (A) | +10,708 | $0 | EDGAR |
| 2021-03-02 | CI | Mixed | +893 | -$617.5K | EDGAR |
| 2021-02-26 | CI | Grant (A) | +1,287 | $0 | EDGAR |
| 2021-02-08 | CI | Tax (F) | −622 | -$130.9K | EDGAR |
| 2021-01-08 | CI | Mixed | +777 | -$317.8K | EDGAR |
| 2020-03-02 | CI | Mixed | −255 | -$442.5K | EDGAR |
| 2020-02-28 | CI | Grant (A) | +1,433 | $0 | EDGAR |